Cortistatin analogues, syntheses, and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10273240
APP PUB NO 20180134725A1
SERIAL NO

15807301

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

New cortistatin compounds and pharmaceutically acceptable salts and pharmaceutically acceptable compositions thereof are provided. These compounds can be used to treat a disorder mediated by CDK8 and/or CDK19 kinase or by the Mediator Complex generally. In particular, the compounds can be used, for example, to treat a disorder such as a tumor, cancer, or a disorder associated with angiogenesis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PRESIDENT AND FELLOWS OF HARVARD COLLEGE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pelish, Henry Efrem Newton, US 15 8
Shair, Matthew D Lexington, US 30 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 30, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 30, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00